|
FY2023
12 months to Aug 31, 2023
|
|
|---|---|
| Revenue | |
| Sales | |
| Royalties and commissions | |
| Total revenue | |
| Costs and Expenses | |
| Cost of products and services sold | |
| Selling, general and administrative expenses | |
| Research and development expense | |
| Operations optimization costs (Note 19) | |
| Acquisition-related costs (Note 14) | |
| Loss on impairment/write-off of long-term assets (Note 3, 8) | |
| Loss on contingent consideration (Note 14) | |
| Operating income | |
| Interest expense | |
| Other (expense) income | |
| Income before income taxes | |
| Income taxes (Note 7) | |
| Net income | |
| Net income available to common shareholders, per common and common equivalent share (Note 4) | |
| Basic | |
| Diluted | |
| Weighted average shares outstanding | |
| Basic | |
| Diluted | |
| Cash dividends paid per share (in dollars per share) |
Loading...
